DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas - Contacts and Locations

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

This study has been completed.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004212

Locations


United States, New York
	Memorial Sloan-Kettering Cancer Center
	New York, New York, United States, 10021

United States, Tennessee
	St. Jude Children's Research Hospital
	Memphis, Tennessee, United States, 38105-2794

United States, Texas
	Children's Medical Center of Dallas
	Dallas, Texas, United States, 75235
	Institute for Drug Development
	San Antonio, Texas, United States, 78245-3217

Sponsors and Collaborators

Daiichi Sankyo Inc.

Investigators


Study Chair:	Robert L. DeJager, MD, FACP	Daiichi Sankyo Inc.